TY - JOUR T1 - Treating allergic bronchopulmonary aspergillosis: the way forward JF - European Respiratory Journal JO - Eur Respir J SP - 385 LP - 387 DO - 10.1183/13993003.01816-2015 VL - 47 IS - 2 AU - Richard B. Moss Y1 - 2016/02/01 UR - http://erj.ersjournals.com/content/47/2/385.abstract N2 - Allergic bronchopulmonary mycoses are an endotype of allergic lung disease, similar to but more severe than uncomplicated asthma, caused by a Th2-dominated immune response and a bronchocentric granulocytic inflammation provoked by endobronchial growth of filamentous fungi in individuals with innate host defence defects (primarily people with severe allergic asthma or cystic fibrosis); untreated, it leads to progressive structural damage [1–3]. The scope of this problem, however, has only been recognised recently [4, 5].ABPA remains a difficult disease to control and entails troubling steroid toxicity http://ow.ly/V4mrR ER -